| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,347 | 3,639 | 4,262 | 1,817 | 157 |
| Cost of Revenue
|
-- | -- | -- | -- | 0 |
|
Gross Profit
|
3,639 | 3,639 | 4,262 | 1,817 | 157 |
|
Selling, General and Administrative Expenses
|
-20,895 | -26,905 | -30,797 | -28,914 | -10,974 |
|
Research and Development Expenses
|
-37,394 | -44,198 | -50,429 | -42,367 | -11,553 |
|
Operating Income/Expenses
|
-58,289 | -71,103 | -81,226 | -71,281 | -22,527 |
|
Total Operating Profit/Loss
|
-53,942 | -67,464 | -76,964 | -69,464 | -22,370 |
| Total Net Finance Income/Expense
|
-36,680 | -35,043 | -33,559 | -18,365 | -87 |
| Irregular Income/Expenses
|
-9,115 | -30,065 | -181,432 | -249,419 | 0 |
|
Other Income/Expense, Non-Operating
|
132 | 400 | 9,271 | -395 | 5,566 |
|
Non-Operating Income/Expenses, Total
|
-45,663 | -64,708 | -205,720 | -268,179 | 5,479 |
|
Pretax Income
|
-99,605 | -132,172 | -282,684 | -337,643 | -16,891 |
|
Provision for Income Tax
|
-13 | -29 | -29 | 4 | 0 |
|
Net Income from Continuing Operations
|
-99,618 | -132,201 | -282,713 | -337,639 | -16,891 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-99,618 | -132,201 | -282,713 | -337,639 | -16,891 |
|
Non-Controlling/Minority Interests
|
1,424 | 5,116 | 31,325 | 70,012 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
-98,194 | -127,085 | -251,388 | -267,627 | -16,891 |
|
Net Income Available to Common Stockholders
|
-98,194 | -127,085 | -251,388 | -267,627 | -16,891 |
|
Diluted Net Income Available to Common Stockholders
|
-98,194 | -127,085 | -251,388 | -267,627 | -16,891 |
| Basic EPS
|
-1.64 | -2.78 | -10.83 | -25.95 | -18.36 |
| Diluted EPS
|
-1.64 | -2.78 | -10.83 | -25.95 | -18.36 |
|
Basic Weighted Average Shares Outstanding
|
62,085.9140 | 45,757.3760 | 23,222.2560 | 10,314.5540 | 919.9590 |
|
Diluted Weighted Average Shares Outstanding
|
62,085.9140 | 45,757.3760 | 23,222.2560 | 10,314.5540 | 919.9590 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-62,925 | -97,129 | -249,125 | -319,278 | -16,804 |
|
EBITDA
|
-57,852 | -91,206 | -242,266 | -314,585 | -15,270 |
|
Normalized EBITDA
|
-42,004 | -53,359 | -59,050 | -47,723 | -16,392 |
|
Normalized Income
|
-87,098.0800 | -97,902.3700 | -99,871.6400 | -70,777.2093 | -18,013 |
|
Total Unusual Items
|
15,848 | 37,847 | 183,216 | 266,862 | -1,122 |
|
Total Unusual Items Excluding Goodwill
|
15,848 | 16,897 | 1,784 | 17,443 | -1,122 |
12/31/2022 - 7/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade